Aristides Capital »

Lenz Therapeutics shares owned by Aristides Capital

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Aristides Capital from 13F filings

Historical chart of Aristides Capital investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Aristides Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Aristides Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $168k 11k 16.00

More positions owned by Aristides Capital

Ishares Bitcoin Trust Etf Call Call Option
D-wave Quantum Put Put Option
Ishares Bitcoin Trust Etf Put Put Option
Tesla Put Put Option
Rigetti Computing Put Put Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ionq Put Put Option
Alphabet Cap Stk Cl A (GOOGL)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Carvana Put Put Option
Robinhood Mkts Put Put Option
Ituran Location And Control SHS (ITRN)
Ishares Silver Tr Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Turning Pt Brands (TPB)

View all positions for Aristides Capital

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
UBS Group
BlackRock
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Adage Capital Partners GP
Intrinsic Edge Capital Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops
Standard Life Aberdeen

View all funds holding Lenz Therapeutics